Guided Therapeutics (GTHP) Depreciation and Depletion (2022 - 2025)

Guided Therapeutics' Depreciation and Depletion history spans 6 years, with the latest figure at $3000.0 for Q4 2025.

  • On a quarterly basis, Depreciation and Depletion rose 50.0% to $3000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $10000.0, a 11.11% increase, with the full-year FY2025 number at $10000.0, up 11.11% from a year prior.
  • Depreciation and Depletion hit $3000.0 in Q4 2025 for Guided Therapeutics, up from $2000.0 in the prior quarter.
  • Over the last five years, Depreciation and Depletion for GTHP hit a ceiling of $2.3 million in Q3 2023 and a floor of $1000.0 in Q3 2022.
  • Historically, Depreciation and Depletion has averaged $167571.4 across 4 years, with a median of $2000.0 in 2023.
  • Biggest five-year swings in Depreciation and Depletion: surged 231500.0% in 2023 and later tumbled 99.91% in 2024.
  • Tracing GTHP's Depreciation and Depletion over 4 years: stood at $3000.0 in 2022, then tumbled by 33.33% to $2000.0 in 2023, then changed by 0.0% to $2000.0 in 2024, then soared by 50.0% to $3000.0 in 2025.
  • Business Quant data shows Depreciation and Depletion for GTHP at $3000.0 in Q4 2025, $2000.0 in Q3 2025, and $3000.0 in Q2 2025.